SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-126318
Filing Date
2020-04-29
Accepted
2020-04-29 16:36:56
Documents
1
Group Members
FHMLS IX, L.L.C.FHMLS IX, L.P.JAMES TOPPERPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A #1 d922780dsc13da.htm SC 13D/A 103774
  Complete submission text file 0001193125-20-126318.txt   105394
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences IX, L.P. (Filed by) CIK: 0001720320 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Subject) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91075 | Film No.: 20830921
SIC: 2834 Pharmaceutical Preparations